Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taclonex Gel and Ointment in Scalp and Body Psoriasis
NCT00279162Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcipotriol + betamethasone in psoriasis (2 arms), sponsored by LEO Pharma. Primary endpoint: Patients with clear or minimal disease of the scalp at 8 weeks. Started Dec 2005; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00279162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00279162.